Article Text
PDFPostScript
Letter
Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial
Statistics from Altmetric.com
Footnotes
Funding S Vermeire and V De Preter are postdoctoral fellows of the Fund for Scientific Research-Flanders, Belgium (F.W.O.-Vlaanderen). Sachets of oligofructose-enriched inulin and maltodextrin were provided by Beneo-Orafti, Belgium.
Competing interests None to declare.
Ethics approval The clinical trial was approved by the ethics committee of the Catholic University of Leuven (study number: ML4789).
Provenance and peer review Not commissioned; internally peer reviewed.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.